Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wei Fan Sui

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Oncotarget|November 16, 2017
Percutaneous laser ablation for benign thyroid nodules: a meta-analysisWei Fan Sui, Jian Yun Li, Jian Hua Fu
World Journal of Clinical Oncology|April 5, 2024
Transarterial chemoembolization plus stent placement for hepatocellular carcinoma with main portal vein tumor thrombosis: A meta-analysisWei-Fan Sui, Jian-Yun Li, Jian-Hua Fu
World Journal of Surgical Oncology|June 4, 2016
The Diagnosis of Metastatic Axillary Lymph Nodes of Breast Cancer By Diffusion Weighted Imaging: a meta-analysis and systematic reviewWei Fan Sui, Xiang Chen, Zhen Kun Peng, et al.
BMC Gastroenterology|July 10, 2026
Transarterial chemoembolization combined with tyrosine kinase inhibitors and programmed death-1 inhibitors in recurrent intermediate and advanced hepatocellular carcinoma: a single-centre retrospective cohort studyWei Fan Sui, Yu Xin Duan, Ze Feng Cai, et al.
World Journal of Clinical Cases|April 25, 2024
Safety and efficacy of transcatheter arterial embolization in autosomal dominant polycystic kidney patients with gross hematuria: Six case reportsWei-Fan Sui, Yun-Xin Duan, Jian-Yun Li, et al.
International Journal of Hepatology|September 22, 2025
Adverse Reactions of First-Line Tyrosine Kinase Inhibitors in Advanced Hepatocellular Carcinoma Treatment: A Descriptive Analysis From WHO-VigiAccessWei Fan Sui, Yu Xin Duan, Ze Feng Cai, et al.
BMC Cancer|August 9, 2025
Adverse drug reaction to tremelimumab and durvalumab in hepatocellular carcinoma patients: an analysis of the food and drug administration adverse event reporting system databaseWei Fan Sui, Yu Xin Duan, Ze Feng Cai, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Oncotarget|November 16, 2017
Percutaneous laser ablation for benign thyroid nodules: a meta-analysisWei Fan Sui, Jian Yun Li, Jian Hua Fu
World Journal of Clinical Oncology|April 5, 2024
Transarterial chemoembolization plus stent placement for hepatocellular carcinoma with main portal vein tumor thrombosis: A meta-analysisWei-Fan Sui, Jian-Yun Li, Jian-Hua Fu
World Journal of Surgical Oncology|June 4, 2016
The Diagnosis of Metastatic Axillary Lymph Nodes of Breast Cancer By Diffusion Weighted Imaging: a meta-analysis and systematic reviewWei Fan Sui, Xiang Chen, Zhen Kun Peng, et al.
BMC Gastroenterology|July 10, 2026
Transarterial chemoembolization combined with tyrosine kinase inhibitors and programmed death-1 inhibitors in recurrent intermediate and advanced hepatocellular carcinoma: a single-centre retrospective cohort studyWei Fan Sui, Yu Xin Duan, Ze Feng Cai, et al.
World Journal of Clinical Cases|April 25, 2024
Safety and efficacy of transcatheter arterial embolization in autosomal dominant polycystic kidney patients with gross hematuria: Six case reportsWei-Fan Sui, Yun-Xin Duan, Jian-Yun Li, et al.
International Journal of Hepatology|September 22, 2025
Adverse Reactions of First-Line Tyrosine Kinase Inhibitors in Advanced Hepatocellular Carcinoma Treatment: A Descriptive Analysis From WHO-VigiAccessWei Fan Sui, Yu Xin Duan, Ze Feng Cai, et al.
BMC Cancer|August 9, 2025
Adverse drug reaction to tremelimumab and durvalumab in hepatocellular carcinoma patients: an analysis of the food and drug administration adverse event reporting system databaseWei Fan Sui, Yu Xin Duan, Ze Feng Cai, et al.
Pageof 1